High Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD): to Load or Maintain (HEIRLOOM)
Clinical trial NCT07129239 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07129239
- Sponsor
- Clinique de Retine de l'est
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-20
- Primary completion
- 2027-02-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.